The Strategic Lever in Biomanufacturing 4.0: Discussion from the September 2025 Talent Boardroom at Biotech Week Boston
Over the past decade, biopharmaceutical manufacturers have invested heavily in expanded production capacity and rapid integration of automation and digitalization. Despite those advances, a paradox has emerged in which physical and technological …